TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.74 -0.26 (-35.79%) 0.0 (-0.65%) -0.01 (-1.31%) -0.2 (-29.87%) -0.26 (-35.79%) 0.42 (94.36%) -0.14 (-16.57%) -0.37 (-43.64%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.2455
Diluted P/E:
-0.2455
RSI(14) 1m:
49.19
VWAP:
0.48
RVol:
0.5787

Events

Period Kind Movement Occurred At
1m Price decrease 1m 0.73 -0.01 (-1.96%) Oct 15 16:16
1m Price decrease 1m 0.73 -0.01 (-1.96%) Oct 15 16:16
1m Price decrease 1m 0.73 -0.01 (-1.96%) Oct 15 16:16
1m Price decrease 1m 0.73 -0.01 (-1.96%) Oct 15 16:16
1m Price decrease 1m 0.73 -0.01 (-1.96%) Oct 15 16:16

Related News